- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MKGAY.PK Market Currents
more »
-
November 18, 2011 ADRs of German chemical and pharmaceutical maker Merck KGaA (MKGAY.PK +0.7%) get a lift after receiving a positive opinion from a committee of the European Medicines Agency for its application to extend the indication of Rebif, its leading treatment for relapsing forms of multiple sclerosis.
Comment![Global & FX, Healthcare, On the Move]
MKGAY.PK in Focus
more »
MKGAY.PK Related Articles
more »
MKGAY.PK News
more »
Currently, there are no news on MKGAY.PK.
MKGAY.PK Press Releases and Filings
more »
Currently, there are no press releases or filings on MKGAY.PK.
MKGAY.PK Latest Transcript
more »
Currently, there are no transcripts for MKGAY.PK.
MKGAY.PK Cramer
more »
-
Wed, Sep 22, 2010
MKGAY.PK Instablog posts
more »
MKGAY.PK vs. ETF Alternatives
Company Description
Currently, there's no company description for MKGAY.PK.